U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H34O11
Molecular Weight 534.5523
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ARCTIIN

SMILES

COC1=CC=C(C[C@H]2COC(=O)[C@@H]2CC3=CC=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(OC)=C3)C=C1OC

InChI

InChIKey=XOJVHLIYNSOZOO-SWOBOCGESA-N
InChI=1S/C27H34O11/c1-33-18-6-4-14(10-20(18)34-2)8-16-13-36-26(32)17(16)9-15-5-7-19(21(11-15)35-3)37-27-25(31)24(30)23(29)22(12-28)38-27/h4-7,10-11,16-17,22-25,27-31H,8-9,12-13H2,1-3H3/t16-,17+,22+,23+,24-,25+,27+/m0/s1

HIDE SMILES / InChI

Molecular Formula C27H34O11
Molecular Weight 534.5523
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/18288407 https://www.ncbi.nlm.nih.gov/pubmed/15042601

Arctiin, isolated from Forsythia suspensa has been reported to have anti-inflammatory, anti-oxidant, antibacterial, and antiviral effects in vitro. It has been found to act as agonist of the adiponectin receptor 1. Has a potential role in the treatment of obesity. Arctiin has being shown to have anticancer effects in animal research.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Differential in vitro anti-HIV activity of natural lignans.
1990 Nov-Dec
The content of lignan glycosides in Forsythia flowers and leaves.
2004 Jul-Aug
A high performance liquid chromatography method for the simultaneous determination of arctiin, chlorogenic acid and glycyrrhizin in a Chinese proprietary medicine.
2005 Sep 15
Antiviral activity of berberine and related compounds against human cytomegalovirus.
2007 Mar 15
Dibenzylbutyrolactone lignans from Forsythia koreana fruits attenuate lipopolysaccharide-induced inducible nitric oxide synthetase and cyclooxygenase-2 expressions through activation of nuclear factor-κb and mitogen-activated protein kinase in RAW264.7 cells.
2010
Determination of the major constituents in fruit of Arctium lappa L. by matrix solid-phase dispersion extraction coupled with HPLC separation and fluorescence detection.
2010 Oct 15
Patents

Sample Use Guides

STZ-induced diabetic rats were treated with arctiin at the dosage of 60 or 40 mg/kg/day via intraperitoneal injection for 8 weeks.
Route of Administration: Intraperitoneal
Arctiin treatment of 3T3-L1 pre-adipocytes markedly decreased adipogenesis in a dose-dependent manner (12.5 to 100 uM).
Substance Class Chemical
Created
by admin
on Fri Dec 15 20:15:09 GMT 2023
Edited
by admin
on Fri Dec 15 20:15:09 GMT 2023
Record UNII
TM5RQ949K7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ARCTIIN
INCI  
INCI  
Official Name English
ARCTIGENIN-4-GLUCOSIDE
Common Name English
NSC-315527
Code English
2(3H)-FURANONE, 4-((3,4-DIMETHOXYPHENYL)METHYL)-3-((4-(.BETA.-D-GLUCOPYRANOSYLOXY)-3-METHOXYPHENYL)METHYL)DIHYDRO-, (3R-TRANS)-
Common Name English
2(3H)-FURANONE, 4-((3,4-DIMETHOXYPHENYL)METHYL)-3-((4-(.BETA.-D-GLUCOPYRANOSYLOXY)-3-METHOXYPHENYL)METHYL)DIHYDRO-, (3R,4R)-
Common Name English
ARCTII
Common Name English
ARCTIIN [INCI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1145
Created by admin on Fri Dec 15 20:15:09 GMT 2023 , Edited by admin on Fri Dec 15 20:15:09 GMT 2023
Code System Code Type Description
PUBCHEM
100528
Created by admin on Fri Dec 15 20:15:09 GMT 2023 , Edited by admin on Fri Dec 15 20:15:09 GMT 2023
PRIMARY
EPA CompTox
DTXSID20942519
Created by admin on Fri Dec 15 20:15:09 GMT 2023 , Edited by admin on Fri Dec 15 20:15:09 GMT 2023
PRIMARY
NCI_THESAURUS
C93250
Created by admin on Fri Dec 15 20:15:09 GMT 2023 , Edited by admin on Fri Dec 15 20:15:09 GMT 2023
PRIMARY
MESH
C077992
Created by admin on Fri Dec 15 20:15:09 GMT 2023 , Edited by admin on Fri Dec 15 20:15:09 GMT 2023
PRIMARY
FDA UNII
TM5RQ949K7
Created by admin on Fri Dec 15 20:15:09 GMT 2023 , Edited by admin on Fri Dec 15 20:15:09 GMT 2023
PRIMARY
NSC
315527
Created by admin on Fri Dec 15 20:15:09 GMT 2023 , Edited by admin on Fri Dec 15 20:15:09 GMT 2023
PRIMARY
WIKIPEDIA
ARCTIIN
Created by admin on Fri Dec 15 20:15:09 GMT 2023 , Edited by admin on Fri Dec 15 20:15:09 GMT 2023
PRIMARY
CAS
20362-31-6
Created by admin on Fri Dec 15 20:15:09 GMT 2023 , Edited by admin on Fri Dec 15 20:15:09 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
TARGET -> AGONIST
PARENT -> CONSTITUENT ALWAYS PRESENT
36% Cell growth rate of M1 cells at 50 uM of compound vs control
Related Record Type Details
ACTIVE MOIETY